RS Research

About:

RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.

Website: http://www.rsresearch.net

Twitter/X: rs_research_tr

Top Investors: ACT Venture Partners, Gen Pharmaceuticals, İstanbul Portföy Yönetimi, Eczacıbasi Momentum

Description:

RS Research is a clinical-stage biotechnology start-up developing novel nanomedicines. We have discovered a novel drug delivery platform with which we currently have development programs in various preclinical and clinical stages for therapies to treat patients fighting cancer. Our nanocarrier platform (Sagitta®) is highly tunable with a plug & play approach, allowing rapid development of targeted nanomedicines with superior performance aiming multiple indications. Along with moving our own candidates toward clinic, we provide preclinical services to industrial and academic partners. We have specific expertise in biosimilar characterization as well as in vivo experiment design and implementation. Our GMP certified production facility is the first cytotoxic-capable clinical batch-size contract organization for such services in the region.